← Back to Search

Consultation for Gastric Cancer

N/A

Waitlist Available

Led By Kuang-Yi Wen, MD

Research Sponsored by Thomas Jefferson University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 2 months

Awards & highlights

Study Summary

This trial is testing a new system that sends patients information and tips about chemotherapy side effects and how to cope with them, in real time.

Eligible Conditions

Gastric Cancer
Esophageal Carcinoma
Pancreatic Cancer
Colorectal Cancer
Esophageal Adenocarcinoma
Esophageal Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 2 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 2 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 2 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability

Feasibility and Engagement

Functional Assessment of Cancer Treatment - General scale

+6 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Health Services Research (RT-CAMSS)Experimental Treatment3 Interventions

Patients receive RT-CAMSS over 2 months or until chemotherapy is discontinued, whichever is earlier. RT-CAMSS consists of text messages addressing knowledge about specific cancer type and chemotherapy, side-effect prevention, suggestions of lifestyle behavioral changes and emotional support, and preparation for surgery. Patients then record their symptoms through answering a series of questionnaires and receive tailored feedback according to their answers, including a consultation with a nurse.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Thomas Jefferson UniversityLead Sponsor

445 Previous Clinical Trials

145,680 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,657 Previous Clinical Trials

40,933,633 Total Patients Enrolled

Kuang-Yi Wen, MDPrincipal InvestigatorThomas Jefferson University Hospital, Philadelphia, PA 19107 USA

1 Previous Clinical Trials

332 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities for volunteers to join this clinical experiment at the moment?

"Affirmative. Clinicaltrials.gov states that this research is recruiting participants since it was initially published on April 15th 2020, and the last edit occured on September 7th 2022. The trial aims to recruit 65 patients from a single site."

Answered by AI

What is the scope of participation in this trial?

"Affirmative. Clinicaltrials.gov data verifies that this research trial, which first went live on April 15th 2020, is currently soliciting participants. 65 patients are being sought from a single medical centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study

2020. "Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04449679.